Jacobs Receives Contract for New Hospital Project in Belgium

Tuesday, September 11, 2007 General News J E 4
PASADENA, Calif., Sept. 11 Jacobs EngineeringGroup Inc. (NYSE: JEC) announced today that it received a contract from theBORDET Institute to provide owner-engineer support for a new 220-bed, 53,000square meter hospital in Brussels, Belgium. BORDET Institute is aworld-renowned institute for cancer identification and treatment.

Officials did not disclose the contract value; however, they noted thatthe total investment cost for the new hospital is over Euro 140 million.

Jacobs already completed a conceptual study for the project. Under the newcontract, it will provide programming and advice for technical and functionalproject definition; support contractor selection; change managementassistance; and will ensure that hospital functions remain stable duringconstruction. Jacobs will continue to manage the project from its healthcareCenter of Excellence in Paris, France.

In making the announcement, Jacobs Group Vice President Andy Kremer said,"This award reflects the BORDET Institute's confidence in our high-valueservices, which we first delivered to them several years ago on programmingstudies. The Institute's new cancer management hospital will incorporate thelatest technologies and communications tools to achieve their objectives forthis vital facility. Our experts will continue to contribute to theInstitute's success for the benefit of their patients."

Jacobs, with over 48,000 employees and revenues exceeding $8.0 billion,provides technical, professional, and construction services globally.

Any statements made in this release that are not based on historical factare forward-looking statements. Although such statements are based onmanagement's current estimates and expectations, and currently availablecompetitive, financial, and economic data, forward-looking statements areinherently uncertain. We, therefore, caution the reader that there are avariety of factors that could cause business conditions and results to differmaterially from what is contained in our forward-looking statements. For adescription of some of the factors which may occur that could cause actualresults to differ from our forward-looking statements please refer to our 2006Form 10-K, and in particular the discussions contained under Items 1 --Business, 1A -- Risk Factors, 3 -- Legal Proceedings, and 7 -- Management'sDiscussion and Analysis of Financial Condition and Results of Operations. Wealso caution the readers of this release that we do not undertake to updateany forward-looking statements made herein.For additional information contact: Mary Bloom 626.578.6992 (Logo:

SOURCE Jacobs Engineering Group Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
OTN Refinances With $300 Million Revolving Loan Ar...
Enobia Pharma Raises $40.1 Million Series B Financ...